FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Tennvall

Research Profile

Procedures

Chemicals & Drugs

Disorders

Living Beings

Devices

Radiometry

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sten Nilsson; Charles Gillies O'Bryan-Tear; Christopher Parker; Ulf Petersson; Katharine Pigott; Michael Sokal; Jan Tennvall; Marcus Thuresson; Christopher Tyrrell; René Blom; Bjørg Bolstad; Lars Franzén; Dag Clement Johannessen; Bo Lennernäs; Oyvind S Bruland
Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases.
Sophie E Eriksson; Holger Jensen; Sture Lindegren; Rune Nilsson; Tom Bäck; Erika Elgström; Jan Tennvall
Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb.
Sophie Leboulleux; Laurence Leenhardt; Muriel Licour; Ahmad Awada; Lars Bastholt; Françoise Bonichon; Christelle de la Fouchardiere; José Manuel Gómez; Thomas Krause; Christine Soufflet; Jan Tennvall; Martin J Schlumberger
Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Tennvall (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sten Nilsson; Charles Gillies O'Bryan-Tear; Christopher Parker; Ulf Petersson; Katharine Pigott; Michael Sokal; Jan Tennvall; Marcus Thuresson; Christopher Tyrrell; René Blom; Bjørg Bolstad; Lars Franzén; Dag Clement Johannessen; Bo Lennernäs; Oyvind S Bruland
Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases.
Clinical genitourinary cancer 2013;11(1):20-6.
2013: Sophie E Eriksson; Holger Jensen; Sture Lindegren; Rune Nilsson; Tom Bäck; Erika Elgström; Jan Tennvall
Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb.
EJNMMI research 2013;3(1):23.
2012: Sophie Leboulleux; Laurence Leenhardt; Muriel Licour; Ahmad Awada; Lars Bastholt; Françoise Bonichon; Christelle de la Fouchardiere; José Manuel Gómez; Thomas Krause; Christine Soufflet; Jan Tennvall; Martin J Schlumberger
Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.
The lancet oncology 2012;13(9):897-905.
2012: Erik Larsson; Michael Ljungberg; Linda Martensson; Rune Nilsson; Sven-Erik Strand; Jan Tennvall; Bo-Anders Jonsson
Use of Monte Carlo simulations with a realistic rat phantom for examining the correlation between hematopoietic system response and red marrow absorbed dose in Brown Norway rats undergoing radionuclide therapy with (177)Lu- and (90)Y-BR96 mAbs.
Medical physics 2012;39(7):4434-43.
2012: Sophie E Eriksson; Rune Nilsson; Tomas Ohlsson; Jan Tennvall
Treatment with unlabeled mAb BR96 after radioimmunotherapy with 177Lu-DOTA-BR96 in a syngeneic rat colon carcinoma model.
Cancer biotherapy & radiopharmaceuticals 2012;27(3):175-82.
2012: Sophie E Eriksson; Rune Nilsson; Tomas Ohlsson; Jan Tennvall
Repeated radioimmunotherapy with 177Lu-DOTA-BR96 in a syngeneic rat colon carcinoma model.
Cancer biotherapy & radiopharmaceuticals 2012;27(2):134-40.
2012: Erika Elgström; Sophie E Eriksson; Tomas G Ohlsson; Jan Tennvall; Rune Nilsson
Pattern of antigen expression in metastases after radioimmunotherapy of a syngeneic rat colon carcinoma utilizing the BR96 antibody.
Experimental hematology & oncology 2012;1(1):34.
2011: Francesco Giammarile; Mark W Konijnenberg; Françoise Kraeber-Bodere; Bieke Lambert; Markus Luster; Jan Tennvall; Lisa Bodei; Françoise Borson-Chazot; Boudewijn Brans; Carlo Chiesa; Glenn Flux; Flavio Forrer
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
European journal of nuclear medicine and molecular imaging 2011;38(7):1393-406.
2011: Rune Nilsson; Sophie E Eriksson; Hans-Olov Sjögren; Jan Tennvall
Different toxicity profiles for drug- versus radionuclide-conjugated BR96 monoclonal antibodies in a syngeneic rat colon carcinoma model.
Acta oncologica (Stockholm, Sweden) 2011;50(5):711-8.
2011: K Sjögreen-Gleisner; Yuni K Dewaraja; C Chiesa; Jan Tennvall; Ola Lindén; Sven-Erik Strand; Michael Ljungberg
Dosimetry in patients with B-cell lymphoma treated with [(90)Y]ibritumomab tiuxetan or [(131)I]tositumomab.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2011;55(2):126-54.
2011: Svante Jansson; Robert Eggertsen; Torsten Grunditz; Johan Molne; Ernst Nyström; Eva Reihnér; Lars Rostgård Christensen; Jan Tennvall
[Quality shortages in the diagnostics of thyroid nodules. National guidelines should be introduced].
Läkartidningen 2011;108(12):664-8.
2010: David Minarik; Katarina Sjögreen-Gleisner; Ola Linden; Karin Wingårdh; Jan Tennvall; Sven-Erik Strand; Michael Ljungberg
90Y Bremsstrahlung imaging for absorbed-dose assessment in high-dose radioimmunotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(12):1974-8.
2010: Michael Garkavij; Mattias Nickel; Katarina Sjögreen-Gleisner; Michael Ljungberg; Tomas Ohlsson; Karin Wingårdh; Sven-Erik Strand; Jan Tennvall
177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.
Cancer 2010;116(4 Suppl):1084-92.
2010: Rune Nilsson; Linda Mårtensson; Sophie E Eriksson; Hans-Olov Sjögren; Jan Tennvall
Toxicity-reducing potential of extracorporeal affinity adsorption treatment in combination with the auristatin-conjugated monoclonal antibody BR96 in a syngeneic rat tumor model.
Cancer 2010;116(4 Suppl):1033-42.
2010: Linda Mårtensson; Rune Nilsson; Tomas Ohlsson; Hans-Olov Sjögren; Sven-Erik Strand; Jan Tennvall
High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model: evaluation of toxicity, therapeutic effect, and tumor model.
Cancer 2010;116(4 Suppl):1043-52.
2009: Jacek Toporski; Michael Garkavij; Jan Tennvall; Ingrid Øra; Katarina Sjögreen Gleisner; Josefina Dykes; Stig Lenhoff; Gunnar Juliusson; Stefan Scheding; Dominik Turkiewicz; Albert N Békássy
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1077-85.
2008: Gertrud Berg; Lars Jacobsson; Ernst Nyström; Katarina Sjögreen Gleisner; Jan Tennvall
Consequences of inadvertent radioiodine treatment of Graves' disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing?
Acta oncologica (Stockholm, Sweden) 2008;47(1):145-9.
2007: Wim J G Oyen; Lisa Bodei; Francesco Giammarile; Helmut R Maecke; Jan Tennvall; M Luster; Boudewijn Brans
Targeted therapy in nuclear medicine--current status and future prospects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1782-92.
2007: Linda Mårtensson; Rune Nilsson; Tomas Ohlsson; Hans Sjögren; Sven-Erik Strand; Jan Tennvall
Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5572s-5576s.
2007: Jan Tennvall; Boudewijn Brans
EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseases.
European journal of nuclear medicine and molecular imaging 2007;34(8):1324-7.
2007: Sten Nilsson; Lars Franzén; Christopher Parker; Christopher Tyrrell; René Blom; Jan Tennvall; Bo Lennernäs; Ulf Petersson; Dag Clement Johannessen; Michael Sokal; Katharine Pigott; Jeffrey Yachnin; Michael Garkavij; Peter Strang; Johan Harmenberg; Bjørg Bolstad; Oyvind S Bruland
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.
The lancet oncology 2007;8(7):587-94.
2007: Amir H Iranpour Feridani; Bo Holmqvist; Hans Sjögren; Sven-Erik Strand; Jan Tennvall; Bo Baldetorp
Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2007;71(6):361-70.
2007: Boudewijn Brans; Lisa Bodei; Francesco Giammarile; O Linden; M Luster; Wim J G Oyen; Jan Tennvall
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
European journal of nuclear medicine and molecular imaging 2007;34(5):772-86.
2007: Linda Mårtensson; Rune Nilsson; Hans Sjögren; Sven-Erik Strand; Jan Tennvall
A nonsurgical technique for blood access in extracorporeal affinity adsorption of antibodies in rats.
Artificial organs 2007;31(4):312-6.
2007: Jan Tennvall; Manfred Fischer; Angelika Bischof Delaloye; Emilio Bombardieri; Lisa Bodei; Francesco Giammarile; Michael Lassmann; Wim Oyen; Boudewijn Brans
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin).
European journal of nuclear medicine and molecular imaging 2007;34(4):616-22.
2007: Jan Kurkus; Rune Nilsson; Ola Lindén; Niki Schönström; Bengt E B Sandberg; Jan Tennvall
Biocompatibility of a novel avidin-agarose adsorbent for extracorporeal removal of redundant radiopharmaceutical from the blood.
Artificial organs 2007;31(3):208-14.
2007: Linda Mårtensson; Rune Nilsson; Tomas Ohlsson; Hans Sjögren; Sven-Erik Strand; Jan Tennvall
Reduced myelotoxicity with sustained tumor concentration of radioimmunoconjugates in rats after extracorporeal depletion.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(2):269-76.
2006: Boudewijn Brans; Ola Linden; Francesco Giammarile; Jan Tennvall; Cornelis Punt
Clinical applications of newer radionuclide therapies.
European journal of cancer (Oxford, England : 1990) 2006;42(8):994-1003.
2006: G Grafström; B-A Jönsson; A M El Hassan; Jan Tennvall; Sven-Erik Strand
Rat testis as a radiobiological in vivo model for radionuclides.
Radiation protection dosimetry 2006;118(1):32-42.
2005: Michael Garkavij; Miroslav Samarzija; Sven B Ewers; Marko Jakopovic; Stanko Tezak; Jan Tennvall
Concurrent radiotherapy and tumor targeting with 111In-HMFG1-F(ab')2 in patients with MUC1-positive non-small cell lung cancer.
Anticancer research 2005;25(6C):4663-71.
2005: Zhongmin Wang; Linda Mårtensson; Rune Nilsson; Pär-Ola Bendahl; Lars Lindgren; Tomas Ohlsson; Hans Sjögren; Sven-Erik Strand; Jan Tennvall
Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7171s-7177s.
2005: Linda Mårtensson; Zhongmin Wang; Rune Nilsson; Tomas Ohlsson; Peter D Senter; Hans Sjögren; Sven-Erik Strand; Jan Tennvall
Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7104s-7108s.
2005: Ola Lindén; Jan Kurkus; Michael Garkavij; Eva Cavallin-Ståhl; Michael Ljungberg; Rune Nilsson; Tomas Ohlsson; Bengt E B Sandberg; Sven-Erik Strand; Jan Tennvall
A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.
Cancer biotherapy & radiopharmaceuticals 2005;20(4):457-66.
2005: Ola Lindén; Cecilia Hindorf; Eva Cavallin-Ståhl; William A Wegener; David M Goldenberg; Heather Horne; Tomas Ohlsson; Lars Stenberg; Sven-Erik Strand; Jan Tennvall
Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5215-22.
2005: Cecilia Hindorf; Ola Lindén; Jan Tennvall; Karin Wingårdh; Sven-Erik Strand
Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy.
Acta oncologica (Stockholm, Sweden) 2005;44(6):579-88.
2004: Jan Akervall; Xiang Guo; Chao-Nan Qian; Jacqueline Schoumans; Brandon Leeser; Eric J Kort; Andrew Cole; James Resau; Carol R Bradford; Thomas Carey; Johan Wennerberg; Harald Anderson; Jan Tennvall; Bin Tean Teh
Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8204-13.
2004: Eva Brun; Jan Tennvall; Bo Baldetorp; Elisabeth Kjellén; Ghita Fallenius; Johan Wennerberg
DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma.
Acta oto-laryngologica 2004;124(6):712-9.
2004: Göran Wallin; Göran Lundell; Jan Tennvall
Anaplastic giant cell thyroid carcinoma.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2004;93(4):272-7.
2003: Cecilia Hindorf; Ola Lindén; Lars Stenberg; Jan Tennvall; Sven-Erik Strand
Change in tumor-absorbed dose due to decrease in mass during fractionated radioimmunotherapy in lymphoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):4003S-6S.
2003: Zhongmin Wang; Michael Garkavij; Tomas Ohlsson; Sven-Erik Strand; Hans Sjögren; Jan Tennvall
Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.
Cancer biotherapy & radiopharmaceuticals 2003;18(3):365-75.
2003: Jörgen Carlsson; Eva Forssell-Aronsson; Sven-Ola Hietala; Torgny Stigbrand; Jan Tennvall
Tumour therapy with radionuclides: assessment of progress and problems.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;66(2):107-17.
2002: Jan Tennvall; Göran Lundell; Peter Wahlberg; Anders Bergenfelz; Lars Grimelius; Måns Akerman; A-L Hjelm Skog; Göran Wallin
Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery.
British journal of cancer 2002;86(12):1848-53.
2002: Zhongmin Wang; Michael Garkavij; Jan Tennvall; Tomas Ohlsson; Sven-Erik Strand; Hans Sjögren
Application of extracorporeal immunoadsorption to reduce circulating blood radioactivity after intraperitoneal administration of indium-111-HMFG1-biotin.
Cancer 2002;94(4 Suppl):1287-92.
2002: Ola Lindén; Cecilia Hindorf; Jan Tennvall; Sverker Segrén; Karin Wingardh; Sven-Erik Strand
Single tumor cell uptake and dosimetry of technetium-99m Fab' or minute anti-CD22 in low-grade B-cell lymphoma.
Cancer 2002;94(4 Suppl):1270-4.
2002: Cecilia Hindorf; Ola Lindén; Jan Tennvall; Karin Wingårdh; Sven-Erik Strand
Time dependence of the activity concentration ratio of red marrow to blood and implications for red marrow dosimetry.
Cancer 2002;94(4 Suppl):1235-9.
2002: Eva Brun; Elisabeth Kjellén; Jan Tennvall; Tomas Ohlsson; Anders Sandell; Roland Perfekt; Roland Perfekt; Johan Wennerberg; Sven-Erik Strand
FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.
Head & neck 2002;24(2):127-35.
2002: Ola Lindén; Jan Tennvall; Cecilia Hindorf; Eva Cavallin-Ståhl; Karl-Johan Lindner; Tomas Ohlsson; Karin Wingårdh; Sven-Erik Strand
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.
Acta oncologica (Stockholm, Sweden) 2002;41(3):297-303.
2002: Jenny Andersson; Barbro Linderholm; Gudrun Greim; Birgitta Lindh; Henrik Lindman; Jan Tennvall; Lena Tennvall-Nittby; Dagny Pettersson-Sköld; Asgerdur Sverrisdottir; Martin Söderberg; Sigrid Klaar; Jonas Bergh
A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in Sweden.
Acta oncologica (Stockholm, Sweden) 2002;41(3):276-81.
2001: Eva Brun; U Zätterström; Elisabeth Kjellén; Peter Wahlberg; R Willén; A Brun; Roland Perfekt; Jan Tennvall
Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomas.
Acta oncologica (Stockholm, Sweden) 2001;40(4):491-6.
2000: Jan Tennvall; E Brun
[PET in Lund--some information].
Läkartidningen 2000;97(25):3112.
2000: Jan Tennvall; Per-Anders Abrahamsson; Göran Ahlgren; L Darte; Per Flodgren; Michael Garkavij; Sven-Erik Strand
Palliative radiation with a radiolabeled diphosphonate (rhenium-186 etidronate) in patients with hormone-refractory disseminated prostate carcinoma.
Scandinavian journal of urology and nephrology 2000;34(3):188-93.
1999: Pia Lindblom; Stig Valdemarsson; Johan Westerdahl; Jan Tennvall; Anders Bergenfelz
Hyperthyroidism after surgery for primary hyperparathyroidism.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 1999;384(6):568-75.
1999: Ola Lindén; Jan Tennvall; Eva Cavallin-Ståhl; L Darte; Michael Garkavij; K J Lindner; Michael Ljungberg; Tomas Ohlsson; Katarina Sjögreen; Karin Wingårdh; Sven-Erik Strand
Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3287s-3291s.
1999: Michael Garkavij; Jan Tennvall; Tomas Ohlsson; Lars Lindgren; Cecilia Hindorf; Hans Sjögren; Sven-Erik Strand
Comparison of 125I- and (111)In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorption.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3059s-3064s.
1998: O Nilsson; J Lindeberg; Jan Zedenius; E Ekman; Jan Tennvall; Henric Blomgren; Lars Grimelius; Göran Lundell; Göran Wallin
Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period.
World journal of surgery 1998;22(7):725-30.
1997: Jan Tennvall; Michael Garkavij; J Chen; Hans Sjögren; Sven-Erik Strand
Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96.
Cancer 1997;80(12 Suppl):2411-8.
1997: J Q Chen; Sven-Erik Strand; Jan Tennvall; Lars Lindgren; Cecilia Hindorf; Hans Sjögren
Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1934-9.
1997: I Malmberg; U Persson; A Ask; Jan Tennvall; Per-Anders Abrahamsson
Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy.
Urology 1997;50(5):747-53.
1997: Michael Garkavij; Jan Tennvall; Sven-Erik Strand; Hans Sjögren; C JianQing; Rune Nilsson; M Isaksson
Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):895-901.
1997: Anders Bergenfelz; Jan Tennvall; S Valdermarsson; Pia Lindblom; Sten Tibblin
Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: a prospective comparative study in patients with predominantly mild primary hyperparathyroidism.
Surgery 1997;121(6):601-5.
1997: Eva Brun; Tomas Ohlsson; Kjell Erlandsson; Elisabeth Kjellén; Anders Sandell; Jan Tennvall; Johan Wennerberg; Sven-Erik Strand
Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET.
Acta oncologica (Stockholm, Sweden) 1997;36(7):741-7.
1996: Michael Garkavij; Jan Tennvall; Sven-Erik Strand; Rune Nilsson; L Lindgren; J Chen; M Isaksson; H Eriksson; Hans Sjögren
Extracorporeal immunoadsorption from whole blood based on the avidin-biotin concept. Evaluation of a new method.
Acta oncologica (Stockholm, Sweden) 1996;35(3):309-12.
1995: Michael Garkavij; Jan Tennvall; Sven-Erik Strand; K Norrgren; L Lindgren; Rune Nilsson; Hans Sjögren
Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in rats.
Cancer research 1995;55(23 Suppl):5874s-5880s.
1994: Michael Garkavij; Jan Tennvall; Sven-Erik Strand; K Norrgren; Rune Nilsson; Hans Sjögren
Improving radioimmunotargeting of tumors: the impact of preloading unlabeled L6 monoclonal antibody on the biodistribution of 125I-L6 in rats.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1994;38(4):594-600.
1994: Sven-Erik Strand; M Ljungberg; Jan Tennvall; K Norrgren; Michael Garkavij
Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorption.
Medical & biological engineering & computing 1994;32(5):551-61.
1994: Jan Tennvall; G Lundell; Arne Hallquist; Peter Wahlberg; Göran Wallin; Sten Tibblin
Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group.
Cancer 1994;74(4):1348-54.
1994: Sven-Erik Strand; K Norrgren; Michael Garkavij; L Lindgren; Rune Nilsson; Hans Sjögren; Jan Tennvall
A general extracorporeal immunoadsorption method to increase tumor-to-tissue ratio.
Cancer 1994;73(3 Suppl):1033-7.
1993: Michael Garkavij; Jan Tennvall; Sven-Erik Strand; K Norrgren; Rune Nilsson; L Lindgren; Hans Sjögren
Improving radioimmonotargeting of tumors. Variation in the amount of L6 MAb administered, combined with an immunoadsorption system (ECIA).
Acta oncologica (Stockholm, Sweden) 1993;32(7-8):853-9.
1993: Sven-Erik Strand; B A Jönsson; M Ljungberg; Jan Tennvall
Radioimmunotherapy dosimetry--a review.
Acta oncologica (Stockholm, Sweden) 1993;32(7-8):807-17.
1992: Lars-Erik Holm; P Hall; Göran Lundell; G Berg; G Bjelkengren; U B Ericsson; Jan Tennvall; Arne Hallquist; M Lidberg; K Wiklund
[Low risk of cancer after treatment of hyperthyroidism with iodine-131].
Läkartidningen 1992;89(38):3043-6.
1992: P Hall; J D Boice; G Berg; G Bjelkengren; U B Ericsson; Arne Hallquist; M Lidberg; Göran Lundell; A Mattsson; Jan Tennvall
Leukaemia incidence after iodine-131 exposure.
Lancet 1992;340(8810):1-4.
1992: Maria Albertsson; Jan Tennvall; T Andersson; A Biörklund; A Elner; L Johansson
Malignant melanoma of the nasal cavity and nasopharynx treated with cisplatin and accelerated hyperfractionated radiation.
Melanoma research 1992;2(2):101-4.
1992: Anders Bergenfelz; Jan Tennvall; Bo Ahrén
Thallium-technetium subtraction scintigraphy of enlarged parathyroid glands after calcitonin stimulation of parathyroid hormone secretion.
Acta radiologica (Stockholm, Sweden : 1987) 1992;33(4):319-22.
1992: P Hall; G Berg; G Bjelkengren; J D Boice; U B Ericsson; Arne Hallquist; M Lidberg; Göran Lundell; Jan Tennvall; K Wiklund
Cancer mortality after iodine-131 therapy for hyperthyroidism.
International journal of cancer. Journal international du cancer 1992;50(6):886-90.
1991: P Hall; Lars-Erik Holm; Göran Lundell; G Bjelkengren; L G Larsson; S Lindberg; Jan Tennvall; H Wicklund; J D Boice
Cancer risks in thyroid cancer patients.
British journal of cancer 1991;64(1):159-63.
1991: Jan Tennvall; Maria Albertsson; A Biörklund; Johan Wennerberg; H Anderson; T Andersson; A Elner; Claes Mercke
Induction chemotherapy (cisplatin + 5-fluorouracil) and radiotherapy in advanced squamous cell carcinoma of the head and neck.
Acta oncologica (Stockholm, Sweden) 1991;30(1):27-32.
1991: Claes Mercke; Maria Albertsson; G Hambraeus; Jan Tennvall; Ramon Lillo-Gil; L Samuelsson; Roger Willén; Jonas Ranstam
Cisplatin and 5-FU combined with radiotherapy and surgery in the treatment of squamous cell carcinoma of the esophagus. Palliative effects and tumor response.
Acta oncologica (Stockholm, Sweden) 1991;30(5):617-22.
1990: W R Cameron; L Johansson; Jan Tennvall
Small cell carcinoma of the parotid. Fine needle aspiration and immunochemical findings in a case.
Acta cytologica 1990;34(6):837-41.
1990: L Johansson; Jan Tennvall; Måns Akerman
Immunohistochemical examination of 25 cases of Merkel cell carcinoma: a comparison with small cell carcinoma of the lung and oesophagus, and a review of the literature.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1990;98(8):741-52.
1990: Jan Tennvall; L Johansson; Maria Albertsson
Small cell carcinoma of the oesophagus: a clinical and immunohistopathological review.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1990;16(2):109-15.
1990: Jan Tennvall; E Tallroth; A el Hassan; G Lundell; Måns Akerman; A Biörklund; H Blomgren; T Löwhagen; Göran Wallin
Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery.
Acta oncologica (Stockholm, Sweden) 1990;29(8):1025-8.
1989: Jan Tennvall; A Biörklund; L Johansson; Måns Akerman
Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathological study of 17 patients.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1989;15(1):1-9.
1988: L Darte; Jan Tennvall
Enhanced therapeutic tumour dose of 131I-MIBG by accelerated diuresis.
European journal of nuclear medicine 1988;14(9-10):512-4.
1988: Jan Tennvall; L Darte; R Lundgren; A M el Hassan
Palliation of multiple bone metastases from prostatic carcinoma with strontium-89.
Acta oncologica (Stockholm, Sweden) 1988;27(4):365-9.
1987: Jan Tennvall; Eva Cavallin-Ståhl; Måns Akerman
Primary localized non-Hodgkin's lymphoma of the thyroid: a retrospective clinicopathological review.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1987;13(4):297-302.
1987: Jan Tennvall; M Olsson; T Möller; Måns Akerman; J Ranstam; A Biörklund; H Mårtensson; B Persson
Thyroid tissue characterization by proton magnetic resonance relaxation time determination.
Acta oncologica (Stockholm, Sweden) 1987;26(1):27-32.
1986: Jan Tennvall; A Biörklund; T Möller; J Ranstam; M Akerman
Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up.
Cancer 1986;57(7):1405-14.
1985: M Akerman; Jan Tennvall; A Biörklund; H Mårtensson; T Möller
Sensitivity and specificity of fine needle aspiration cytology in the diagnosis of tumors of the thyroid gland.
Acta cytologica 1985;29(5):850-5.
1985: Jan Tennvall; A Biörklund; T Möller; J Ranstam; M Akerman
Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Retrospective multivariate analysis of 216 patients with a median follow-up of 11 years.
Acta radiologica. Oncology 1985;24(1):17-24.
1984: Jan Tennvall; J Palmer; A Biörklund; T Möller; J Ranstam; M Akerman
Kinetics of 201Tl uptake in adenomas and well-differentiated carcinomas of the thyroid. A double isotope investigation with 99Tcm and 201Tl.
Acta radiologica. Oncology 1984;23(1):55-9.
1983: Jan Tennvall; E Cederquist; T Möller; Y Naversten; M Akerman
Preoperative scintigraphy with correlation to cytology and histopathology in carcinoma of the thyroid.
Acta radiologica. Oncology 1983;22(3):183-91.
1981: Jan Tennvall; J Palmer; E Cederquist; I Larsson; A Biörklund; S Ingemansson; M Akerman
Scintigraphic evaluation and dynamic studies with thallium-201 in thyroid lesions with suspected cancer.
European journal of nuclear medicine 1981;6(7):295-300.